SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 1/14/21 Cell MedX Corp. 10-Q 11/30/20 53:2M Empire Stock Transf… Inc |
Document/Exhibit Description Pages Size 1: 10-Q Quarterly Report HTML 286K 2: EX-10.30 Loan Agreement and Note Payable Dated September 2, HTML 19K 2020, Among Cell Medx Corp. and Rain Communications Corp. 3: EX-10.31 Loan Agreement and Note Payable Dated October 26, HTML 20K 2020, Among Cell Medx Corp. and Rain Communications Corp. 4: EX-31.1 Certification -- §302 - SOA'02 HTML 18K 5: EX-31.2 Certification -- §302 - SOA'02 HTML 18K 6: EX-32.1 Certification -- §906 - SOA'02 HTML 16K 7: EX-32.2 Certification -- §906 - SOA'02 HTML 16K 14: R1 Document and Entity Information HTML 64K 15: R2 Condensed Consolidated Balance Sheets HTML 82K 16: R3 Condensed Consolidated Balance Sheets - HTML 23K Parenthetical 17: R4 Condensed Consolidated Statements of Operations HTML 74K 18: R5 Condensed Consolidated Statement of Stockholders' HTML 60K Deficit 19: R6 Condensed Consolidated Statements of Cash Flows HTML 83K 20: R7 Organization and Nature of Operations HTML 22K 21: R8 Related Party Transactions Disclosure HTML 31K 22: R9 Inventory Disclosure HTML 18K 23: R10 Other Current Assets Disclosure HTML 18K 24: R11 Equipment Disclosure HTML 23K 25: R12 Revenue Disclosure HTML 26K 26: R13 Notes and Advances Payable Disclosure HTML 38K 27: R14 Share Capital Disclosure HTML 40K 28: R15 Related Party Transactions Disclosure: Schedule of HTML 24K Amounts Due to Related Parties (Tables) 29: R16 Related Party Transactions Disclosure: Schedule of HTML 22K Transactions with Related Parties (Tables) 30: R17 Equipment Disclosure: Change in book value of the HTML 22K equipment (Tables) 31: R18 Revenue Disclosure: Schedule of Revenue and HTML 26K Associated Costs (Tables) 32: R19 Notes and Advances Payable Disclosure: Schedule of HTML 33K Short-term Loans and Advances Outstanding (Tables) 33: R20 Share Capital Disclosure: Schedule of Stock Option HTML 24K Activity (Tables) 34: R21 Share Capital Disclosure: Schedule of Stock HTML 22K Options Outstanding (Tables) 35: R22 Share Capital Disclosure: Schedule of Warrant HTML 24K Activity (Tables) 36: R23 Share Capital Disclosure: Schedule of Warrant HTML 23K Details (Tables) 37: R24 Organization and Nature of Operations (Details) HTML 20K 38: R25 Related Party Transactions Disclosure: Schedule of HTML 33K Amounts Due to Related Parties (Details) 39: R26 Related Party Transactions Disclosure: Schedule of HTML 26K Transactions with Related Parties (Details) 40: R27 Inventory Disclosure (Details) HTML 21K 41: R28 Other Current Assets Disclosure (Details) HTML 20K 42: R29 Equipment Disclosure: Change in book value of the HTML 26K equipment (Details) 43: R30 Revenue Disclosure: Schedule of Revenue and HTML 35K Associated Costs (Details) 44: R31 Notes and Advances Payable Disclosure: Schedule of HTML 44K Short-term Loans and Advances Outstanding (Details) 45: R32 Notes and Advances Payable Disclosure (Details) HTML 34K 46: R33 Share Capital Disclosure (Details) HTML 29K 47: R34 Share Capital Disclosure: Schedule of Stock Option HTML 26K Activity (Details) 48: R35 Share Capital Disclosure: Schedule of Stock HTML 28K Options Outstanding (Details) 49: R36 Share Capital Disclosure: Schedule of Warrant HTML 25K Activity (Details) 50: R37 Share Capital Disclosure: Schedule of Warrant HTML 33K Details (Details) 52: XML IDEA XML File -- Filing Summary XML 89K 51: EXCEL IDEA Workbook of Financial Reports XLSX 44K 8: EX-101.INS XBRL Instance -- cmxc-20201130 XML 553K 10: EX-101.CAL XBRL Calculations -- cmxc-20201130_cal XML 60K 11: EX-101.DEF XBRL Definitions -- cmxc-20201130_def XML 235K 12: EX-101.LAB XBRL Labels -- cmxc-20201130_lab XML 436K 13: EX-101.PRE XBRL Presentations -- cmxc-20201130_pre XML 372K 9: EX-101.SCH XBRL Schema -- cmxc-20201130 XSD 100K 53: ZIP XBRL Zipped Folder -- 0001393905-21-000010-xbrl Zip 51K
ex-10.30 |
LOAN
AGREEMENT
Rain Communications Corp. (the “Lender”) with an address at 1130 West Pender Street, Unit 820, Vancouver, BC V6E 4A4, advanced USD$6,000 (the “Principal Sum”) to Cell MedX Corp. (the “Borrower”) of 123 W. Nye Ln, Suite 446, Carson City, NV 89706. The Lender advanced the funds on September 2, 2020.
The Borrower agrees to repay the Principal Sum on demand, together with interest calculated and compounded monthly at the rate of 6% per year (the “Interest”) calculated from September 2, 2020 (the “Effective Date”). The Borrower is liable for repayment of the Principal Sum, accrued Interest, and any additional costs that the Lender incurs in trying to collect the amount owed to him under the terms of this Loan Agreement.
The Borrower will evidence the debt and its repayment of the Principal Sum and the Interest with a promissory note in the attached form.
LENDER | BORROWER |
Rain Communications Corp. | Cell MedX Corp. |
|
|
Per: | Per: |
|
|
|
|
/s/ Raph Biggar | /s/ Yanika Silina |
Raph Biggar, President | Yanika Silina, CFO |
PROMISSORY NOTE
Principal Amount: USD$6,000 |
FOR VALUE RECEIVED Cell MedX Corp., (the “Borrower”) promises to pay on demand to the order of Rain Communications Corp. (the “Lender”) the sum of $6,000 lawful money of the United States of America (the “Principal Sum”) together with the Interest accrued on the Principal Sum calculated from September 2, 2020 (“Effective Date”) both before and after maturity, default and judgment at the Interest Rate as defined below.
For the purposes of this promissory note, Interest Rate means 6 per cent per year. Interest at the Interest Rate must be calculated and compounded monthly not in advance from and including the Effective Date (for an effective rate of 6.2% per annum calculated monthly), and is payable together with the Principal Sum when the Principal Sum is repaid.
The Borrower may repay the Principal Sum, and the Interest in whole or in part at any time.
The Borrower waives presentment, protest, notice of protest and notice of dishonour of this promissory note.
BORROWER
Cell MedX Corp.
Per:
/s/ Yanika Silina
Yanika Silina, CFO
This ‘10-Q’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 1/14/21 | None on these Dates | ||
For Period end: | 11/30/20 | |||
9/2/20 | ||||
List all Filings |